Cost-effectiveness of enhancing adherence to therapy with blood pressure-lowering drugs in the setting of primary cardiovascular prevention


To estimate the cost-effectiveness of enhancing adherence to bloodpressure (BP)-lowering drug therapy in a large population withoutsigns of preexisting cardiovascular (CV) disease.

Value in Health
Gianluca Baio
Gianluca Baio
Professor of Statistics and Health Economics